The metabolic disturbances and hyperglycemia in diabetic ischemic heart disease might alter the activity of kinases and transcription factors like DNA-PK, CDC2, MYC, SP1, and CREB1, exacerbating cardiac dysfunction. This evidence concerns the gene CREB1 and Hyperglycemia.